• Adam BD, Maticka-Tyndale E & Cohen JJ (2003) Adherence practices among people living with HIV. AIDS Care 15, 263274.
  • Bennett DE, Bertagnolio S, Sutherland D & Gilks CF (2008) The World Health Organization’s Global Strategy for Prevention and Assessment of HIV Drug Resistance. WHO, Geneva.
  • Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
  • HIV Unit, MoH (2008) ARV Therapy in Malawi – up to 31st December 2008. Quarterly Report. MoH, Lilongwe.
  • Hogg RS, Heath K, Bangsberg D et al. (2002) Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 16, 10511058.
  • Mocroft A, Youle M, Moore A et al. (2001) Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS 15, 185194.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4, e298.
  • UNAIDS (2009) Report on the Global AIDS Epidemic. UNAIDS, Geneva.
  • Vreeman RC, Nyandiko WM, Sang E et al. (2009) Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya. Confl Health 3, 5.
  • WHO (2006) Progress on Global Access to HIV Antiviral Therapy: Report on ‘3 by 5’ and Beyond WHO, Geneva.
  • Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bulletin of the World Health Organization 85, 550554.